Caris Life Sciences, Inc. (CAI) Key Statistics & Financial Ratios

Caris Life Sciences, Inc. (CAI) — Price $30.39 — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Key statistics dashboard for Caris Life Sciences, Inc. (CAI). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms.

Stock Data

Price$30.39
Market Cap$8.6B
Enterprise Value$8.35B
Beta1.33
ExchangeNASDAQ
CountryUS

Valuation Multiples

P/E Ratio81.72
Price / Book14.53
P/S8.68
EV/EBITDA48.37
EV/Sales8.44
EV/FCF57.02
P/FCF58.64
Earnings Yield1.22%
FCF Yield1.71%
Dividend Yield0.00%

Profitability

Gross Margin69.66%
EBIT Margin15.35%
EBITDA Margin17.45%
Operating Margin15.49%
Net Margin10.62%
Return on Equity18.77%
Return on Assets8.55%
Return on Invested Capital14.67%
Return on Capital Employed14.76%

Financial Health

Current Ratio5.53
Quick Ratio4.88
Cash Ratio3.61
Debt / Equity0.76
Debt / Assets36.79%
Net Debt / EBITDA-1.38
Interest Coverage3.27
Piotroski F-Score6
Altman Z-Score6.95

Per-Share Data

Revenue per share3.50
Book Value per share2.09
Cash per share2.80
FCF per share0.52
Tangible Book Value per share2.02
Dividend per share0.00

Analyst Consensus

Strong Buy0
Buy6
Hold1
Sell0
Strong Sell0
Total analysts7
Avg rating (1-5)0.86

Related companies: ABVX · CORT · CYTK · HALO · JAZZ · MDGL · MRNA

Explore sector: Healthcare · Biotechnology

More sections of CAI: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks